Statement Of Cash Flows [Abstract]

Medicover - Filing #690784

Concept 2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Adjustments for finance income (cost)
318,000,000 EUR
191,000,000 EUR
Cash flows from (used in) operations before changes in working capital
2,101,000,000 EUR
2,576,000,000 EUR
Adjustments for decrease (increase) in trade and other receivables
267,000,000 EUR
495,000,000 EUR
Adjustments for increase (decrease) in trade and other payables
259,000,000 EUR
257,000,000 EUR
Adjustments for depreciation and amortisation expense and impairment loss (reversal of impairment loss) recognised in profit or loss
1,619,000,000 EUR
1,110,000,000 EUR
Cash flows from (used in) investing activities [abstract]
Dividends received from associates, classified as investing activities
1,000,000 EUR
1,000,000 EUR
Proceeds from disposal of non-current assets or disposal groups classified as held for sale and discontinued operations
30,000,000 EUR
21,000,000 EUR
Purchase of property, plant and equipment, intangible assets other than goodwill, investment property and other non-current assets
1,406,000,000 EUR
1,022,000,000 EUR
Purchase of investments other than investments accounted for using equity method
5,000,000 EUR
20,000,000 EUR
Purchase of financial instruments, classified as investing activities
63,000,000 EUR
1,825,000,000 EUR
Proceeds from sales or maturity of financial instruments, classified as investing activities
5,000,000 EUR
EUR
Cash flows from (used in) financing activities [abstract]
Dividends paid to non-controlling interests, classified as financing activities
60,000,000 EUR
67,000,000 EUR
Proceeds from contributions of non-controlling interests
8,000,000 EUR
19,000,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.